37918 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 28
00:43 UTC
|
PETS
PetMed Express
|
◎ Target | Erin Wright ★★★★☆ #539 | Underweight | $2.15→ $1.40-34.9% |
|
Sep 28
00:43 UTC
|
PAYX
Paychex
|
◎ Target | Jared Levine ★★★★★ #127 | Hold | $117.00→ $105.00-10.3% |
|
Sep 28
00:43 UTC
|
PATH
UiPath
|
◎ Target | Radi Sultan ★★★★★ #105 | Neutral | $19.00→ $14.00-26.3% |
|
Sep 28
00:43 UTC
|
P
Everpure
|
◎ Target | Tim Long ★★★☆☆ #1532 | Equal Weight | $110.00→ $132.00+20.0% |
|
Sep 28
00:43 UTC
|
OTB
On the Beach Group
|
◎ Target | firm only | Buy | GBX 240→ GBX 220-8.3% |
|
Sep 28
00:43 UTC
|
OKTA
Okta
|
◎ Target | Keith Bachman ★★★★★ #103 | Outperform | $187.00→ $230.00+23.0% |
|
Sep 28
00:43 UTC
|
OKTA
Okta
|
◎ Target | Todd Weller not yet tracked | Overweight | $190.00→ $240.00+26.3% |
|
Sep 28
00:43 UTC
|
OKTA
Okta
|
◎ Target | Shrenik Kothari ★★★★★ #13 | Outperform | $200.00→ $235.00+17.5% |
|
Sep 28
00:43 UTC
|
OKLO
Oklo
|
◎ Target | Jon Windham ★☆☆☆☆ #3069 | Neutral | $55.00→ $41.00-25.5% |
|
Sep 28
00:43 UTC
|
NTRA
Natera
|
◎ Target | Dan Leonard ★★★★★ #70 | Outperform | $350.00→ $460.00+31.4% |
|
Sep 28
00:43 UTC
|
NKE
NIKE
|
◎ Target | Brooke Roach ★★★☆☆ #1949 | Neutral | $42.00→ $38.00-9.5% |
|
Sep 28
00:43 UTC
|
MS
Morgan Stanley
|
◎ Target | Mike Mayo ★★★★☆ #696 | Equal Weight | $240.00→ $223.00-7.1% |
|
Sep 28
00:43 UTC
|
MNDI
Mondi
|
◎ Target | firm only | Buy | GBX 1,085→ GBX 1,080-0.5% |
|
Sep 28
00:43 UTC
|
META
Meta Platforms
|
◎ Target | John Blackledge ★★★☆☆ #1037 | Buy | $750.00→ $865.00+15.3% |
|
Sep 28
00:43 UTC
|
META
Meta Platforms
|
◎ Target | Benjamin Black not yet tracked | Buy | $750.00→ $820.00+9.3% |
|
Sep 28
00:43 UTC
|
META
Meta Platforms
|
◎ Target | Maria Ripps ★★★☆☆ #1050 | Buy | $930.00→ $950.00+2.2% |
|
Sep 28
00:43 UTC
|
META
Meta Platforms
|
◎ Target | Thomas Champion ★★★☆☆ #1516 | Overweight | $785.00→ $875.00+11.5% |
|
Sep 28
00:43 UTC
|
MDLN
Medline
|
◎ Target | Kevin Caliendo ★★★★☆ #592 | Buy | $45.00→ $43.00-4.4% |
|
Sep 28
00:43 UTC
|
LYB
LyondellBasell Industries
|
◎ Target | Joshua Spector ★★★☆☆ #1883 | Neutral | $64.00→ $62.00-3.1% |
|
Sep 28
00:43 UTC
|
KNF
Knife River
|
◎ Target | Rohit Seth ★★★☆☆ #1433 | Buy | $105.00→ $65.00-38.1% |
|
Sep 28
00:43 UTC
|
KMX
CarMax
|
◎ Target | Jeff Lick ★★☆☆☆ #2636 | Overweight | $66.00→ $74.00+12.1% |
|
Sep 28
00:43 UTC
|
KMB
Kimberly-Clark
|
◎ Target | Anna Lizzul ★★★★☆ #916 | Buy | $122.00→ $120.00-1.6% |
|
Sep 28
00:43 UTC
|
KGC
Kinross Gold
|
◎ Target | Anita Soni ★★★☆☆ #1503 | Outperformer | $54.00→ $50.00-7.4% |
|
Sep 28
00:43 UTC
|
IVZ
Invesco
|
◎ Target | Michael Cyprys ★★★★☆ #934 | Equal Weight | $30.00→ $31.00+3.3% |
|
Sep 28
00:43 UTC
|
IE
Ivanhoe Electric
|
◎ Target | Orest Wowkodaw ★★☆☆☆ #2726 | Sec→ r Outperform | $18.00→ $16.00-11.1% |
|
Sep 28
00:43 UTC
|
HON
Honeywell International
|
◎ Target | firm only | Neutral | $237.00→ $234.00-1.3% |
|
Sep 28
00:43 UTC
|
GWW
W.W. Grainger
|
◎ Target | Guy Hardwick ★★★★☆ #452 | Underweight | $1,185.00→ $1,172.00-1.1% |
|
Sep 28
00:43 UTC
|
GS
The Goldman Sachs Group
|
◎ Target | Mike Mayo ★★★★☆ #696 | Overweight | $1,325.00→ $1,175.00-11.3% |
|
Sep 28
00:43 UTC
|
GRAL
GRAIL
|
◎ Target | Bradley Bowers ★★★★★ #120 | Neutral | $65.00→ $100.00+53.8% |
|
Sep 28
00:43 UTC
|
GIS
General Mills
|
◎ Target | Andrew Lazar ★★★★☆ #898 | Equal Weight | $36.00→ $37.00+2.8% |
|
Sep 28
00:43 UTC
|
GEN
Gen Digital
|
◎ Target | Matthew Hedberg ★★★★★ #169 | Sec→ r Perform | $30.00→ $26.00-13.3% |
|
Sep 28
00:43 UTC
|
GDDY
GoDaddy
|
◎ Target | Vikram Kesavabhotla ★★☆☆☆ #2620 | Outperform | $110.00→ $120.00+9.1% |
|
Sep 28
00:43 UTC
|
FUL
H. B. Fuller
|
◎ Target | Ghansham Panjabi ★★★☆☆ #1540 | Outperform | $75.00→ $65.00-13.3% |
|
Sep 28
00:43 UTC
|
FRVO
Fervo Energy
|
◎ Target | Ross Fowler ★★★☆☆ #2231 | Buy | $36.00→ $30.00-16.7% |
|
Sep 28
00:43 UTC
|
FIS
Fidelity National Information Services
|
◎ Target | David Koning ★★★★☆ #578 | Neutral | $48.00→ $45.00-6.2% |
|
Sep 28
00:43 UTC
|
EMR
Emerson Electric
|
◎ Target | Joe Giordano not yet tracked | Hold | $150.00→ $170.00+13.3% |
|
Sep 28
00:43 UTC
|
DRI
Darden Restaurants
|
◎ Target | Jon Tower ★★★☆☆ #2209 | Buy | $248.00→ $247.00-0.4% |
|
Sep 28
00:43 UTC
|
DRI
Darden Restaurants
|
◎ Target | Andrew Strelzik ★★☆☆☆ #2857 | Market Perform | $225.00→ $220.00-2.2% |
|
Sep 28
00:43 UTC
|
DRI
Darden Restaurants
|
◎ Target | Nick Setyan ★★★☆☆ #1826 | Outperform | $235.00→ $245.00+4.3% |
|
Sep 28
00:43 UTC
|
DMRA
Damora Therapeutics, Inc. Common Stock
|
◎ Target | Brad Canino not yet tracked | Buy | $40.00→ $60.00+50.0% |
|
Sep 28
00:43 UTC
|
CVX
Chevron
|
◎ Target | Kim Fustier ★★★★★ #36 | Buy | $218.00→ $250.00+14.7% |
|
Sep 28
00:43 UTC
|
CTSH
Cognizant Technology Solutions
|
◎ Target | firm only | Neutral | $42.00→ $60.00+42.9% |
|
Sep 28
00:43 UTC
|
CRL
Charles River Laboratories International
|
◎ Target | Justin Bowers ★★★★★ #59 | Buy | $300.00→ $320.00+6.7% |
|
Sep 28
00:43 UTC
|
CRL
Charles River Laboratories International
|
◎ Target | Luke Sergott ★★★★★ #56 | Overweight | $300.00→ $330.00+10.0% |
|
Sep 28
00:43 UTC
|
CRL
Charles River Laboratories International
|
◎ Target | Charles Rhyee ★★★★★ #278 | Buy | $300.00→ $325.00+8.3% |
|
Sep 28
00:43 UTC
|
CRL
Charles River Laboratories International
|
◎ Target | Eric Coldwell ★★★★☆ #434 | Outperform | $291.00→ $334.00+14.8% |
|
Sep 28
00:43 UTC
|
CRL
Charles River Laboratories International
|
◎ Target | Ann Hynes ★★★★★ #33 | Neutral | $264.00→ $295.00+11.7% |
|
Sep 28
00:43 UTC
|
CRL
Charles River Laboratories International
|
◎ Target | Ryan Halsted ★★★★★ #311 | Outperform | $282.00→ $322.00+14.2% |
|
Sep 28
00:43 UTC
|
CPT
Camden Property Trust
|
◎ Target | Michael Lewis ★★★☆☆ #1407 | Buy | $123.00→ $108.00-12.2% |
|
Sep 28
00:43 UTC
|
COST
Costco Wholesale
|
◎ Target | David Belinger not yet tracked | Outperform | $1,100.00→ $1,065.00-3.2% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.